The Path Forward for Infused Biosimilars in the US

In this exclusive PC Podcast interview, Vibhu Tewary, project director, IQVIA Institute for Human Data Science, discusses:

• Highlights of the company’s report surrounding the “Long-term Market Sustainability for Infused Biosimilars in the US: Foundational Analytics on Emerging Risks to Sustainability”
• The process that constructing and piecing together a report of this magnitude entails, along with where the idea itself came from
• The concept of net cost recovery
• The ongoing challenges surrounding ASP-based reimbursement
• A closed-door, multi-stakeholder virtual roundtable (based on his original report) that was previously held

The latest episode of The Pharmaceutical Commerce Podcast is available directly on Audioboom, Spotify, or iHeart.